Key Financial Data Of Group

Kidswell Bio Corporation - Filing #7297119

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
Key financial data of group
Business results of group
Net sales
1,749,911,000 JPY
Ordinary profit (loss)
-267,993,000 JPY
Profit (loss) attributable to owners of parent
-241,794,000 JPY
Comprehensive income
-141,598,000 JPY
Net assets
857,195,000 JPY
Total assets
4,645,792,000 JPY
Basic earnings (loss) per share
-6.09
Diluted earnings per share
Equity-to-asset ratio
0.167 xbrli:pure
Net cash provided by (used in) operating activities
-288,426,000 JPY
Net cash provided by (used in) investing activities
-2,954,000 JPY
Net cash provided by (used in) financing activities
-244,657,000 JPY
Cash and cash equivalents
1,695,373,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.